<?xml version="1.0" encoding="UTF-8"?>
<boxed-text id="Ba" position="float" orientation="portrait">
 <caption>
  <title>Summary</title>
 </caption>
 <sec>
  <title>What is already known about this topic?</title>
  <p>Hepatitis B virus and hepatitis C virus infection prevalences are high in Uzbekistan, which lacks funding for meeting the World Health Organizationâ€™s 2030 elimination targets.</p>
 </sec>
 <sec>
  <title>What is added by this report?</title>
  <p>In December 2019, the Center for Disease Analysis Foundation initiated a pilot treatment program using innovative catalytic funding. During the first 3 months, &gt;24,000 persons were tested and 438 initiated treatment, 87% of whom paid for medications and 14% received free medications.</p>
 </sec>
 <sec>
  <title>What are the implications for public health practice?</title>
  <p>Early results demonstrate willingness of patients to pay for treatment if costs are low, which can offset elimination costs. However, improvements across the continuum of care are needed to recover the upfront investment.</p>
 </sec>
</boxed-text>
